Mezagitamab
- Generic Name
- Mezagitamab
- Drug Type
- Biotech
- CAS Number
- 2227490-52-8
- Unique Ingredient Identifier
- 0XMR8L9LOL
- Background
Mezagitamab is under investigation in clinical trial NCT04278924 (Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Participants With Persistent/chronic Primary Immune Thrombocytopenia).
A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants
- First Posted Date
- 2014-08-18
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 74
- Registration Number
- NCT02219256
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath